New Tooth-Saving materials put to the test against standard treatment

NCT ID NCT07660549

Completed Disease control Sponsor: Cukurova University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three different materials used to treat severe, irreversible tooth inflammation. 72 adults with painful molars received a procedure where the damaged pulp was removed and covered with one of the materials. The goal was to see if newer materials (TheraCal LC and TheraCal PT) work as well as the standard material (MTA) for controlling pain and saving the tooth over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mineral trioxide aggregate, TheraCal LC, and TheraCal PT (dental pulp capping materials)
What this could lead to: If successful, this could show that newer, easier-to-use materials work as well as the standard material for saving teeth with severe pulp inflammation.
What could go wrong: This is a small, completed trial with only 72 participants, so results may not apply to all patients. The materials are already in use, so no major new breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULPITIS - IRREVERSIBLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulpitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PULPITIS - IRREVERSIBLE

Contacts and locations

Locations

Cukurova University

Adana, Sarıçam, 01250, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.